IRB #

STUDY00018754

Title

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical
Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX)

Principal Investigator

Jacqueline Vuky

Study Purpose

The purpose of the FLEX Registry is to extract the full genomic information from the MammaPrint and BluePrint tumor samples utilizing a full genome microarray. The expanded gene expression data in FLEX Registry will be then be linked to clinical, pathological, treatment, and outcome data also collected in this registry. The FLEX Registry will curate a large-scale registry of gene expression data that is coupled with clinical data. This comprehensive database will support the identification of clinically relevant and/or scientifically interesting new gene associations in a population based setting, as well as the post-market validation of existing signatures.

Medical Condition(s)

Breast Cancer

Eligibility Criteria

Stage I-III male or female breast cancer patients who receive MammaPrint with or without BluePrint testing.

Age Range

18 - 105

Healthy Volunteers Needed

No

Duration of Participation

10 years after definitive surgery

Minors Included

No

Contact

Dr. Jacqueline Vuky email: vukyja@ohsu.edu

Sponsor

Agendia

Recruitment End

08/31/2020

Compensation Provided

No


Go Back